Vaxcel Enoxaparin Sodium 4000 IU (40mg)/0.4ml Injection Prefilled Syringe

Manufacturer
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.(CHINA)

Registraction Number
MAL24066009AZ

Content:

• Active Ingredient: Enoxaparin Sodium 4000 IU (40 mg) per 0.4 ml

• Prophylaxis of venous thromboembolic disease in moderate and high-risk surgical patients, especially those undergoing orthopedic or general surgery, including cancer surgery.
• Prevention of thrombus formation in extracorporeal circulation during hemodialysis.
• Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), excluding PE likely to require thrombolytic therapy or surgery.
• Extended treatment of DVT and PE and prevention of its recurrence in patients with active cancer.
• Acute coronary syndrome: Management of acute ST-segment elevation myocardial infarction (STEMI) including patients to be managed medically.

• Prophylaxis in surgical patients: Administer 4000 IU (40 mg) once daily, preferably starting 12 hours before surgery. Continue treatment for 7-10 days for moderate-risk patients, and up to 5 weeks for high-risk patients1.
• Extended prophylaxis: For major orthopedic surgery, continue up to 5 weeks.
• DVT and PE treatment: Dosage should be individualized based on patient condition and healthcare professional's recommendation.